文献速递冠心病外科

多动脉与单动脉冠状动脉手术:100万患者10年随访

Multiarterial vs Single-Arterial Coronary Surgery: 10-Year Follow-up of 1 Million Patients.
PubMed 文献 · Ann Thorac Surg · 2024-01-27

研究比较多动脉移植(MAG)与单动脉移植(SAG)冠状动脉旁路移植术后的长期生存,纳入胸外科医师学会成人心脏手术数据库2008-2019年1,021,632例孤立CABG患者并链接国家死亡指数。风险调整后,MAG与10年生存改善相关(调整后HR 0.86,95%CI 0.85-0.88),在体重指数<40 kg/m2患者中应作为首选多支血管血运重建策略。

要点

  • MAG与10年生存改善相关(调整后HR 0.86,95%CI 0.85-0.88),SAG组为参照。
  • 中心年MAG例数≥10例与获益相关。
  • 体重指数≥40 kg/m2患者中SAG生存更优。

核心结论

  • 多动脉冠状动脉旁路移植与更优长期生存相关,对于体重指数<40 kg/m2的患者应作为外科多支血管血运重建策略的首选。

研究设计与样本

  • 回顾性队列研究,纳入胸外科医师学会成人心脏手术数据库2008-2019年所有接受≥2支血管移植的孤立CABG患者,并链接国家死亡指数;采用逆概率加权和多变量模型进行风险调整;主要终点为纵向生存。

主要发现

  • 共1,021,632例患者在1108个中心接受孤立CABG,其中MAG 100,419例(9.83%),SAG 920,943例(90.17%)。
  • 中位随访5.30年(范围0-12年)。
  • 风险调整后,10年时MAG与改善的未调整生存相关(HR 0.59;95%CI 0.58-0.61)和调整后生存相关(HR 0.86;95%CI 0.85-0.88)。
  • 中心年MAG例数≥10例与获益相关。
  • MAG在所有亚组中均与SAG相比具有总生存优势,包括稳定冠心病、急性冠脉综合征和急性心肌梗死。

临床怎么用

  • 作者认为,多动脉冠状动脉旁路移植与更优长期生存相关,对于体重指数<40 kg/m2的患者应作为外科多支血管血运重建策略的首选。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although many options exist for multivessel coronary revascularization, controversy persists over whether multiarterial grafting (MAG) confers a survival advantage over single-arterial grafting (SAG) with saphenous vein in coronary artery bypass grafting (CABG). This study sought to compare longitudinal survival between patients undergoing MAG and those undergoing SAG. METHODS: All patients undergoing isolated CABG with ≥2 bypass grafts in The Society of Thoracic Surgeons Adult Cardiac Surgery Database (2008-2019) were linked to the National Death Index. Risk adjustment was performed using inverse probability weighting and multivariable modeling. The primary end point was longitudinal survival. Subpopulation analyses were performed and volume thresholds were analyzed to determine optimal benefit. RESULTS: A total of 1,021,632 patients underwent isolated CABG at 1108 programs (100,419 MAG [9.83%]; 920,943 SAG [90.17%]). Median follow-up was 5.30 years (range, 0-12 years). After risk adjustment, all characteristics were well balanced. At 10 years, MAG was associated with improved unadjusted (hazard ratio, 0.59; 95% CI 0.58-0.61) and adjusted (hazard ratio, 0.86; 95% CI, 0.85-0.88) 10-year survival. Center volume of ≥10 MAG cases/year was associated with benefit. MAG was associated with an overall survival advantage over SAG in all subgroups, including stable coronary disease, acute coronary syndrome, and acute infarction. Survival was equivalent to that with SAG for patients age ≥80 years and those with severe heart failure, renal failure, peripheral vascular disease, or obesity. Only patients with a body mass index ≥40 kg/m2 had superior survival with SAG. CONCLUSIONS: Multiarterial CABG is associated with superior long-term survival and should be the surgical multivessel revascularization strategy of choice for patients with a body mass index of less than 40 kg/m2.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Sabik JF, Mehaffey JH, Badhwar V, et al. Multiarterial vs Single-Arterial Coronary Surgery: 10-Year Follow-up of 1 Million Patients. Ann Thorac Surg. 2024. PMID: 38286204. doi:10.1016/j.athoracsur.2024.01.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。